Trial · NCT02465268
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Comparison of Overall Survival (OS) Between the Active Treatment Group (Arms 1 and 2) and the Control Group (Arm 3) | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 16.9 | 95% Confidence Interval 12.7 to 22.8 | months | |
| Comparison of Overall Survival (OS) Between the Active Treatment Group (Arms 1 and 2) and the Control Group (Arm 3) | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 16.2 | 95% Confidence Interval 13.8 to 19.2 | months | |
| Comparison of Overall Survival (OS) Between the Active Treatment Group (Arms 1 and 2) and the Control Group (Arm 3) | Unpulsed PBMC and Saline (Arm 3) | 20.6 | 95% Confidence Interval 15.4 to 30.2 | months | |
| Comparison of Progression-free Survival Between the Active Treatment Group (Arms 1 and 2 Combined) and the Control Group (Arm 3) | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 6.1 | 95% Confidence Interval 3.9 to 11.0 | months | |
| Comparison of Progression-free Survival Between the Active Treatment Group (Arms 1 and 2 Combined) and the Control Group (Arm 3) | Plus pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 6.4 | 95% Confidence Interval 4.2 to 10.8 | months | |
| Comparison of Progression-free Survival Between the Active Treatment Group (Arms 1 and 2 Combined) and the Control Group (Arm 3) | Unpulsed PBMC and Saline (Arm 3) | 7.1 | 95% Confidence Interval 3.9 to 14.8 | months | |
| ELISPOT Assay (pp65) | Arm 1: pp65-shLAMP DC With GM-CSF and Td | 126.3 | Standard Deviation 759.9 | spot forming units (SFU) | |
| ELISPOT Assay (pp65) | Arm 2: pp65-flLAMP DC With GM-CSF and Td | 48.4 | Standard Deviation 377.5 | spot forming units (SFU) | |
| ELISPOT Assay (pp65) | Arm 3: Unpulsed PBMC and Saline | -162.7 | Standard Deviation 1075.4 | spot forming units (SFU) | |
| Flow Cytometric Analysis (T Cell) | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | -0.1 | Standard Deviation 11.1 | percentage of PBMC | |
| Flow Cytometric Analysis (T Cell) | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 5.9 | Standard Deviation 16.6 | percentage of PBMC | |
| Flow Cytometric Analysis (T Cell) | Unpulsed PBMC and Saline (Arm 3) | 1.7 | Standard Deviation 7.0 | percentage of PBMC | |
| Cytokine Array Analysis (IFN-g) | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | -3.5 | Standard Deviation 5.0 | pg/mL | |
| Cytokine Array Analysis (IFN-g) | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 3.3 | Standard Deviation 17.7 | pg/mL | |
| Cytokine Array Analysis (IFN-g) | Unpulsed PBMC and Saline (Arm 3) | -1.7 | Standard Deviation 10.0 | pg/mL | |
| ELISPOT Assay (Actin) | Arm 1: pp65-shLAMP DC With GM-CSF and Td | 0.4 | Standard Deviation 6.0 | spot forming units (SFU) | |
| ELISPOT Assay (Actin) | Arm 2: pp65-flLAMP DC With GM-CSF and Td | -0.2 | Standard Deviation 26.1 | spot forming units (SFU) | |
| ELISPOT Assay (Actin) | Arm 3: Unpulsed PBMC and Saline | -0.4 | Standard Deviation 9.4 | spot forming units (SFU) | |
| Flow Cytometric Analysis (NK Cell) | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | -1.3 | Standard Deviation 11.1 | percentage of PBMC | |
| Flow Cytometric Analysis (NK Cell) | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 5.9 | Standard Deviation 16.6 | percentage of PBMC |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02465268/results